C36H38N6O5 — CID 163557631
N-[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]-4-[4-[[(6aS)-2-methyl-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylpyrrole-2-carboxamide (PubChem CID 163557631) has the molecular formula C36H38N6O5 and a molecular weight of 634.74 g/mol. Its IUPAC name is N-[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]-4-[4-[[(6aS)-2-methyl-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylpyrrole-2-carboxamide.
| Compound Name | N-[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]-4-[4-[[(6aS)-2-methyl-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylpyrrole-2-carboxamide |
|---|---|
| PubChem CID | 163557631 |
| Molecular Formula | C36H38N6O5 |
| Molecular Weight | 634.74 g/mol |
| Exact Mass | 634.29 |
| IUPAC Name | N-[4-(5-acetyl-1-methylpyrrol-3-yl)phenyl]-4-[4-[[(6aS)-2-methyl-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylpyrrole-2-carboxamide |
| SMILES | CC(=O)c1cc(-c2ccc(NC(=O)c3cc(NC(=O)CCCOc4cc5c(cc4C)C(=O)N4CCC[C@H]4C=N5)cn3C)cc2)cn1C |
| InChI | InChI=1S/C36H38N6O5/c1-22-15-29-30(37-19-28-7-5-13-42(28)36(29)46)18-33(22)47-14-6-8-34(44)38-27-17-32(41(4)21-27)35(45)39-26-11-9-24(10-12-26)25-16-31(23(2)43)40(3)20-25/h9-12,15-21,28H,5-8,13-14H2,1-4H3,(H,38,44)(H,39,45)/t28-/m0/s1 |
| InChIKey | GVUWTCJFGDZXGP-NDEPHWFRSA-N |
| XLogP | 5.91 |
| TPSA | 127.03 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 47 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 634.74 |
| LogP ≤ 5 | 5.91 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|